drugset / Trial / NCT01242579
A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to assess the pharmacokinetics of the combination dapivirine and maraviroc gel and determine whether it is safe for daily use by healthy women in the United Kingdom
Timeline
- Start
- 2011-01
- Primary completion
- 2011-07
- Completion
- 2011-07
Outcome
Outcome not reported
Stopped: “In order to focus efforts on the combination ring formulation, IPM decided not to move forward with this trial.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maraviroc | Other / unclassified | 0.1 % | Other |
| Subject | dapivirine | Small molecule | 0.05 % | Other |